|
H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The following were reviewed as part of this investigation: patient severity, complaint and lot history, applicable previous investigation(s), labeling, applicable manufacturing records, and applicable fmea documents.Based on a review of this information, the following was concluded: the complaint of a y-site leak was confirmed but the exact cause remains unknown.One 22 ga x 1 in safestep infusion w/site was returned for investigation.The package label was returned with lot: ascvs0001.The safety mechanism was returned fully activated.The proximal luer hub was flushed with water using a 12 ml syringe and a spraying leak was observed from the y-site hub.Microscopic observation of the leak location revealed two longitudinal cracks in the white portion of the y-site hub.The cracks were located at opposite ends from each other.One of the cracks went along the injection gate location.The cracks extend from the lower end to the top end of the cylindrical region on the white hub.Additional surface damage was not observed.Based on the condition of the returned sample, possible contributing factors include over-tightening and attachment to incompatible component.Since the exact cause to the formation of the cracks remains unknown, the complaint is confirmed but the exact cause remains unknown.A lot history review (lhr) of ascvs0001 showed no other similar product complaint(s) from this lot number.
|